• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三尖瓣缘对缘修复术治疗三尖瓣脱垂和连枷样瓣叶:与继发三尖瓣反流患者相比的可行性。

Tricuspid edge-to-edge repair for tricuspid valve prolapse and flail leaflet: feasibility in comparison to patients with secondary tricuspid regurgitation.

机构信息

Department for Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria.

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

出版信息

Eur Heart J Cardiovasc Imaging. 2024 Feb 22;25(3):365-372. doi: 10.1093/ehjci/jead264.

DOI:10.1093/ehjci/jead264
PMID:37861385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10883724/
Abstract

AIMS

Transcatheter tricuspid edge-to-edge repair (T-TEER) has gained widespread use for the treatment of tricuspid regurgitation (TR) in symptomatic patients with high operative risk. Although secondary TR is the most common pathology, some patients exhibit primary or predominantly primary TR. Characterization of patients with these pathologies in the T-TEER context has not been systematically performed.

METHODS AND RESULTS

Patients assigned to T-TEER by the interdisciplinary heart team were consecutively recruited in two European centres over 4 years. Echocardiographic images were evaluated to distinguish between primary and secondary causes of TR. Both groups were compared concerning procedural results. A total of 339 patients were recruited, 13% with primary TR and 87% with secondary TR. Patients with primary TR had a smaller right ventricle (basal diameter 45 vs. 49 mm, P = 0.004), a better right ventricular function (fractional area change 45 vs. 41%, P = 0.001), a smaller right (28 vs. 34 cm2, P = 0.021) and left (52 vs. 67 mL/m2, P = 0.038) atrium, and a better left ventricular ejection fraction (60 vs. 52%, P = 0.005). The severity of TR was similar in primary and secondary TR at baseline (TR vena contracta width pre-interventional 13 ± 4 vs. 14 ± 5 mm, P = 0.19), and T-TEER significantly reduced TR in both groups (TR vena contracta width post-interventional 4 ± 3 vs. 5 ± 5 mm, P = 0.10). These findings remained stable after propensity score matching. Complications were similar between both groups.

CONCLUSION

T-TEER confers equally safe and effective reduction of TR in patients with primary and secondary TR.

摘要

目的

经导管三尖瓣缘对缘修复术(T-TEER)已广泛应用于高手术风险的症状性三尖瓣反流(TR)患者的治疗。虽然继发性 TR 是最常见的病变,但部分患者存在原发性或主要为原发性 TR。在 T-TEER 背景下,尚未对这些病理患者进行系统特征描述。

方法和结果

在 4 年内,两个欧洲中心的多学科心脏团队连续招募了被分配到 T-TEER 的患者。评估超声心动图图像以区分 TR 的原发性和继发性病因。比较两组患者的手术结果。共纳入 339 例患者,其中 13%为原发性 TR,87%为继发性 TR。原发性 TR 患者的右心室(基底直径 45 比 49mm,P=0.004)较小,右心室功能(分数面积变化 45 比 41%,P=0.001)更好,右心房(28 比 34cm2,P=0.021)和左心房(52 比 67mL/m2,P=0.038)更小,左心室射血分数(60 比 52%,P=0.005)更好。在基线时,原发性和继发性 TR 的 TR 瓣口收缩期宽度相似(TR 瓣口收缩期宽度术前 13±4 比 14±5mm,P=0.19),且 T-TEER 可使两组的 TR 均显著降低(TR 瓣口收缩期宽度术后 4±3 比 5±5mm,P=0.10)。在倾向评分匹配后,这些发现仍然稳定。两组的并发症相似。

结论

T-TEER 可安全有效地降低原发性和继发性 TR 患者的 TR 严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e8/10883724/e6076bd49c63/jead264f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e8/10883724/02f849f59081/jead264_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e8/10883724/24c3f1f93e1a/jead264f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e8/10883724/e6076bd49c63/jead264f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e8/10883724/02f849f59081/jead264_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e8/10883724/24c3f1f93e1a/jead264f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e8/10883724/e6076bd49c63/jead264f2.jpg

相似文献

1
Tricuspid edge-to-edge repair for tricuspid valve prolapse and flail leaflet: feasibility in comparison to patients with secondary tricuspid regurgitation.三尖瓣缘对缘修复术治疗三尖瓣脱垂和连枷样瓣叶:与继发三尖瓣反流患者相比的可行性。
Eur Heart J Cardiovasc Imaging. 2024 Feb 22;25(3):365-372. doi: 10.1093/ehjci/jead264.
2
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry.经导管三尖瓣缘对缘修复术治疗房间隔与室间隔继发三尖瓣反流患者的特征和结局:TriValve 注册研究结果。
Eur J Heart Fail. 2023 Dec;25(12):2243-2251. doi: 10.1002/ejhf.3075. Epub 2023 Nov 8.
3
Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.三尖瓣经导管缘对缘修复术对三尖瓣环直径的影响——来自 TriValve 注册研究的数据。
Int J Cardiol. 2024 Jun 15;405:131934. doi: 10.1016/j.ijcard.2024.131934. Epub 2024 Mar 2.
4
Residual tricuspid regurgitation after tricuspid transcatheter edge-to-edge repair: Insights into the EuroTR registry.三尖瓣经导管缘对缘修复术后残余三尖瓣反流:EuroTR 注册研究的见解。
Eur J Heart Fail. 2024 Aug;26(8):1850-1860. doi: 10.1002/ejhf.3274. Epub 2024 May 29.
5
Impact of Tricuspid Regurgitation on Outcomes of Mitral Valve Surgery after Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术后三尖瓣反流对二尖瓣手术结局的影响。
Semin Thorac Cardiovasc Surg. 2024;36(1):11-25. doi: 10.1053/j.semtcvs.2022.06.021. Epub 2022 Aug 3.
6
Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair.三尖瓣经导管缘对缘修复术后的瓣叶-瓣环指数与残余三尖瓣反流。
EuroIntervention. 2022 Jun 3;18(2):e169-e178. doi: 10.4244/EIJ-D-21-00862.
7
Early and mid-term outcomes of transcatheter tricuspid valve repair: systematic review and meta-analysis of observational studies.经导管三尖瓣修复术的早期和中期结果:观察性研究的系统评价和荟萃分析
Rev Esp Cardiol (Engl Ed). 2023 May;76(5):322-332. doi: 10.1016/j.rec.2022.06.004. Epub 2022 Jun 2.
8
Transcatheter tricuspid valve edge-to-edge repair after a heart transplant: a single-centre experience with a novel therapy†.经心脏移植后的经导管三尖瓣瓣环对瓣修复:一种新型治疗的单中心经验†。
Eur J Cardiothorac Surg. 2023 Jun 1;63(6). doi: 10.1093/ejcts/ezad199.
9
Tricuspid Valve Transcatheter Edge-to-Edge Repair (TriClip): Initial Outcomes and Experience in Türkiye.三尖瓣经导管缘对缘修复术(TriClip):土耳其的初步结果和经验。
Turk Kardiyol Dern Ars. 2024 Sep;52(6):375-383. doi: 10.5543/tkda.2024.34954.
10
Comparison of transcatheter leaflet-approximation and direct annuloplasty in tricuspid regurgitation.经导管瓣叶接近术与直接瓣环成形术治疗三尖瓣反流的比较。
Clin Res Cardiol. 2024 Jan;113(1):126-137. doi: 10.1007/s00392-023-02287-0. Epub 2023 Aug 29.

引用本文的文献

1
Patient Phenotypes Undergoing Tricuspid Transcatheter Edge-to-Edge Repair: Finding the Optimal Candidate.接受三尖瓣经导管缘对缘修复的患者表型:寻找最佳候选人。
J Cardiovasc Dev Dis. 2025 Jul 31;12(8):293. doi: 10.3390/jcdd12080293.
2
Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation.肿瘤疾病对重度单纯三尖瓣反流患者预后的影响。
Eur J Clin Invest. 2025 Mar;55(3):e14367. doi: 10.1111/eci.14367. Epub 2024 Dec 2.
3
Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation.

本文引用的文献

1
Short-Term Outcomes of Tricuspid Edge-to-Edge Repair in Clinical Practice.临床实践中三尖瓣缘对缘修复的短期结果。
J Am Coll Cardiol. 2023 Jul 25;82(4):281-291. doi: 10.1016/j.jacc.2023.05.008. Epub 2023 May 17.
2
Transcatheter Repair for Patients with Tricuspid Regurgitation.经导管三尖瓣反流修复术治疗患者。
N Engl J Med. 2023 May 18;388(20):1833-1842. doi: 10.1056/NEJMoa2300525. Epub 2023 Mar 4.
3
Prevalence and Clinical Implications of Tricuspid Valve Prolapse Based on Magnetic Resonance Diagnostic Criteria.基于磁共振诊断标准的三尖瓣脱垂的患病率及临床意义
原发性三尖瓣反流边缘对边缘修复术后1年三尖瓣反流减少的稳健性。
Clin Res Cardiol. 2025 Feb;114(2):251-260. doi: 10.1007/s00392-024-02549-5. Epub 2024 Sep 24.
4
Time to assess more than prognosis: advancements and challenges in transcatheter tricuspid valve interventions.是时候进行更多预后评估之外的工作了:经导管三尖瓣介入治疗的进展与挑战
Front Cardiovasc Med. 2024 Aug 9;11:1447411. doi: 10.3389/fcvm.2024.1447411. eCollection 2024.
J Am Coll Cardiol. 2023 Jan 27. doi: 10.1016/j.jacc.2022.11.052.
4
Incidence and Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation.心房颤动患者三尖瓣反流的发病率及负担
J Am Coll Cardiol. 2022 Dec 13;80(24):2289-2298. doi: 10.1016/j.jacc.2022.09.045.
5
Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results.经导管三尖瓣修复术治疗三尖瓣反流:PASCAL 系统 TriCLASP 研究 30 天结果。
Catheter Cardiovasc Interv. 2022 Dec;100(7):1291-1299. doi: 10.1002/ccd.30450. Epub 2022 Nov 15.
6
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
7
Invasive Hemodynamic Assessment and Procedural Success of Transcatheter Tricuspid Valve Repair-Important Factors for Right Ventricular Remodeling and Outcome.经导管三尖瓣修复术的有创血流动力学评估及手术成功率——右心室重塑和预后的重要因素
Front Cardiovasc Med. 2022 Jun 2;9:891468. doi: 10.3389/fcvm.2022.891468. eCollection 2022.
8
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study.三尖瓣系统治疗三尖瓣反流患者的 6 个月结果:TRICUS EURO 研究。
JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366-1377. doi: 10.1016/j.jcin.2022.05.022. Epub 2022 May 17.
9
Tricuspid valve prolapse as an early predictor for severe phenotype in children with Marfan syndrome.三尖瓣脱垂作为马凡综合征患儿严重表型的早期预测指标。
Acta Paediatr. 2022 Jun;111(6):1261-1266. doi: 10.1111/apa.16307. Epub 2022 Feb 27.
10
Transcatheter treatment for tricuspid valve disease.经导管三尖瓣疾病治疗。
EuroIntervention. 2021 Nov 19;17(10):791-808. doi: 10.4244/EIJ-D-21-00695.